TxSCO Joins ASCO in Support Letter for HB 293

The Texas Society of Clinical Oncology (TxSCO) and the Association for Clinical Oncology (ASCO) are pleased to support House Bill 293: Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans, which would provide coverage for fertility preservation services for patients with cancer when necessary medical treatments may cause infertility. The House Insurance Committee’s passage of HB 293 would be a crucial step in helping to make Texas the 11th state to provide this important protection for patients with cancer. Read support letter. 

Posted 03/18/2021

Update for MIPS-Eligible Clinicians Affected by Extreme Circumstances

In response to the Federal Emergency Management Agency (FEMA) designation of the Texas Severe Winter Storm as a national disaster, the Centers for Medicare & Medicaid Services has determined that the automatic extreme and uncontrollable circumstances policy will apply to Merit-based Incentive Payment System (MIPS) eligible clinicians in FEMA-identified Texas areas.

MIPS-eligible clinicians in these areas will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. During the data submission period for the 2021 performance period (January 3, 2022 to March 31, 2022), all four performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold. Click here for more information.

Posted 05/13/2021